An in-depth look to HANS BIOMED CORPORATION operating, investing, and financing activities

042520 free cash flow for Q3 24 is -540.38 M KRW. For 2023, 042520 free cash flow was -5.66 B KRW and operating cash flow was -3.73 B KRW.